Cargando…
Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report
The accumulation of amyloid-β protein (Aβ) in the brain signifies a major pathological change of Alzheimer’s disease (AD). Extracorporeal blood Aβ removal system (E-BARS) has been under development as a tool for enhancing the clearance of Aβ from the brain. Previously, we revealed that dialyzers rem...
Autores principales: | Kitaguchi, Nobuya, Kato, Takashi, Matsunaga, Shinji, Hirano, Kyoko, Iwata, Kaori, Kawaguchi, Kazunori, Fujita, Kiyoshi, Takechi, Hajime, Hasegawa, Midori, Yuzawa, Yukio, Ito, Kengo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219271/ https://www.ncbi.nlm.nih.gov/pubmed/30464477 http://dx.doi.org/10.2147/NDT.S186118 |
Ejemplares similares
-
Aβ Influx into the Blood Evoked by Different Blood Aβ Removal Systems: A Potential Therapy for Alzheimer’s Disease
por: Kitaguchi, Nobuya, et al.
Publicado: (2021) -
Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer’s Disease
por: Saito, Yuta, et al.
Publicado: (2020) -
Amyloid-β breaks brain's neuroprotection
por: Wang, Yunling, et al.
Publicado: (2017) -
Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals
por: Park, Chae Jung, et al.
Publicado: (2022) -
Amyloid‐β PET and CSF in an autopsy‐confirmed cohort
por: Reimand, Juhan, et al.
Publicado: (2020)